India, 2026 — Shreedhar Group has announced the launch of the “State of Pharmaceutical QC Laboratories in India 2026”, a new industry research initiative designed to understand the evolving priorities, challenges and technology adoption across pharmaceutical Quality Control (QC) laboratories in India.

The research will gather insights from professionals working across pharmaceutical quality control, quality assurance, analytical laboratories, microbiology, research and development, validation and related laboratory functions.
India's pharmaceutical industry continues to evolve toward greater automation, stronger data integrity, increased regulatory expectations and more technology-driven laboratory operations. Against this backdrop, the study aims to capture the practical experiences of laboratory professionals and identify the issues that are shaping pharmaceutical QC laboratories in 2026.

What Will the Study Examine?
The research will examine several key areas of pharmaceutical laboratory operations, including:
Analytical instrument usage and adoption
Instrument calibration and maintenance
Equipment downtime and service challenges
Laboratory validation practices
Environmental monitoring priorities
Compliance and documentation challenges
Data integrity and laboratory digitalisation
Automation and emerging technologies
Artificial intelligence adoption in QC laboratories
Instrument procurement and supplier selection criteria
Technical support and application-service expectations
Training and skills requirements for laboratory professionals
The findings will be analysed to identify emerging trends, operational challenges and changing priorities among pharmaceutical QC professionals in India.

From Laboratory Challenges to Industry Intelligence

Rather than focusing on individual products or brands, the State of Pharmaceutical QC Laboratories in India 2026 initiative is intended to create an industry-level view of laboratory practices and priorities.
The resulting research will provide quantitative findings, expert perspectives and practical insights that can help laboratory professionals, pharmaceutical companies, technology providers and other industry stakeholders better understand the changing QC environment.

“We want this research to reflect the realities faced by laboratory professionals on the ground,” said Mr. Shreedhhar, Shreedhar Group. “Pharmaceutical QC laboratories are dealing with changing technology requirements, compliance expectations, maintenance challenges and increasing pressure for efficiency. By bringing these experiences together, we hope to create useful industry intelligence rather than another product-focused report.”

Key Areas of Industry Interest
Among the areas being investigated are questions such as:
How are pharmaceutical QC laboratories selecting analytical instruments in 2026?
What are the most common calibration and maintenance challenges?
How important are service response times and technical support when selecting laboratory equipment?
How far has laboratory digitalisation progressed?
Are pharmaceutical QC professionals beginning to use AI and automation in routine laboratory operations?
What skills and capabilities will QC laboratories need in the coming years?
The study will seek to answer these questions through direct responses from professionals working in India's pharmaceutical and life sciences ecosystem.

Research-Based Initiative
Following completion of the survey, Shreedhar Group plans to publish the findings through a comprehensive industry report along with supporting articles, data visualisations and expert commentary.
The research findings will also be developed into focused industry stories covering areas such as:
Pharmaceutical QC instrumentation trends
Calibration and maintenance challenges
Environmental monitoring priorities
Laboratory digitalisation
AI and automation
Instrument procurement behaviour
Technical support expectations
QC laboratory skills and training
This approach is intended to make the research useful not only to laboratory professionals but also to pharmaceutical industry publications, researchers, consultants and other stakeholders looking for current data on India's laboratory ecosystem.
Participate in the Research
Pharmaceutical QC, QA, analytical, microbiology, validation and laboratory professionals in India are invited to contribute their perspectives to the State of Pharmaceutical QC Laboratories in India 2026 study.
Survey: shreedhargroup.com/products
The survey is expected to take approximately 5–7 minutes to complete.
Individual responses will be treated according to the study's stated privacy and research methodology.
About Shreedhar Group
Shreedhar Group operates in the analytical instrumentation and laboratory technology ecosystem, supporting organisations across pharmaceutical, life sciences and environmental monitoring applications.
Through the State of Pharmaceutical QC Laboratories in India 2026, the company aims to contribute original industry intelligence and facilitate greater understanding of the technology, operational and service priorities shaping pharmaceutical laboratories in India.

Media Contact:
Mr. Shreedhar
Shreedhar Group
[email protected]
(0265) 2323041
https://shreedhargroup.com/